Skip to content

Looking to buy stocks? Finbold recommends Interactive Brokers – the most advanced investment platform

0.00% (0.00)
Seelos Therapeutics, Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Venus Concept Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Interactive Strength Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Petros Pharmaceuticals, Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Hempacco Co., Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
ReShape Lifesciences, Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Nuvve Holding Corp. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
SunLink Health Systems, Inc
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Arcimoto, Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
-1.14% (0.00)
Tharimmune, Inc. Common Stock
$0.36
L: 0.36 H: 0.39
Volume 82.69K
Avg. Volume 0
Exchange
0.00% (0.00)
Integrated Media Technology Limited Ordinary Shares
$0.00
Volume 0
Avg. Volume 0
Exchange
-2.04% (-0.08)
Gaxos.ai Inc. Common Stock
$3.93
L: 3.79 H: 4.00
Volume 12.71K
Avg. Volume 0
Exchange
0.00% (0.00)
AERWINS Technologies Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
GT Biopharma Inc. Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
0.00% (0.00)
Catheter Precision, Inc.
$0.58
L: 0.58 H: 0.62
Volume 52.49K
Avg. Volume 0
Exchange
-1.08% (0.00)
NovaBay Pharmaceuticals, Inc.
$0.12
L: 0.11 H: 0.26
Volume 135.16M
Avg. Volume 0
Exchange
-2.00% (-0.04)
Leafly Holdings, Inc. Common Stock
$1.91
L: 1.90 H: 2.10
Volume 34.77K
Avg. Volume 0
Exchange
0.00% (0.00)
Society Pass Incorporated Common Stock
$0.00
Volume 0
Avg. Volume 0
Exchange
-1.16% (-0.04)
NexImmune, Inc. Common Stock
$3.36
L: 3.20 H: 3.49
Volume 5.34K
Avg. Volume 0
Exchange
-4.67% (-0.01)
Nuwellis, Inc. Common Stock
$0.26
L: 0.25 H: 0.32
Volume 5.42M
Avg. Volume 0
Exchange

Looking to buy stocks? Finbold recommends Interactive Brokers – the most advanced investment platform

Weekly Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy